Pelago

The world's first digital clinic for substance use management

New York, United States · Founded 2017 · $122.1M raised

Headquarters
New York, New York
Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$122.1M
Last Round
$58.0M Series CMar 2024
Rounds
3

About

Pelago, formerly Quit Genius, is the world’s leading virtual clinic for substance use management. We are transforming substance use support—from prevention to treatment—delivering education, management skills, and opportunities for positive change to members struggling with substance use, most commonly tobacco, alcohol, or opioids. Our solution gives employers the means to offer on-demand, personalized support to workers seeking to live healthier lives. Pelago’s cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible, and effective support that seamlessly integrates with health plans, pharmacy benefit managers, and wellness platforms. To date, Pelago has helped more than 750,000 members manage their substance use and improve their lives.

Summary

Pelago is a Healthcare company based in New York, United States, founded in 2017. It has raised $122.1M in total across 3 rounds, most recently a $58.0M Series C round in Mar 2024. Investors include Atomico, octopus investments and Kinnevik.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series CSeries CMar 2024
$58.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies